论文信息 - MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC - 字舞流文

MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC

C. Rudin | S. Gettinger | R. Heist | D. Costa | P. Schmid | B. Ma | A. Dowlati | B. Besse | V. Villaflor | A. Cervantes | P. Foster | J. Spahn | G. Hernandez | I. Sarkar | C. O'Hear